Skip to main content

Early versus late ST-segment resolution and clinical outcomes after percutaneous coronary intervention for acute myocardial infarction

Abstract

Background. Absence of complete ST-segment resolution (STR) after percutaneous coronary intervention (PCI) for ST-segment-elevation myocardial infarction (STEMI) is a determinant of mortality. Traditionally, STR is determined on the coronary care unit (CCU) 60 to 90 minutes after the initiation of reperfusion therapy. We studied the prognostic value of STR immediately after PCI.

Methods. We analysed 223 consecutive patients with STEMI and successful PCI. Continuous ECG data were collected during PCI and at 30 minutes after arrival on the CCU (mean time 81±17 minutes after reflow of the culprit artery). Patients were divided into three groups: patients with complete STR immediately after PCI (‘early’), patients with complete and persistent STR at 30 minutes on the CCU, but not immediately after PCI (‘late’) and patients without STR. One-year follow-up was obtained for death and rehospitalisation for major adverse cardiac events. Cox proportional hazards regression was used to evaluate the association between STR and outcome.

Results. Early STR occurred in 115 (52%) and late STR in 43 (19%) patients. Patients with early or late STR had a lower incidence of one-year cardiac death than those without STR (1.9 vs. 9.2%; p=0.02). In contrast, rehospitalisation occurred more frequently in patients with early or late STR (20.3 vs. 6.2%; p=0.009). As compared with patients without STR, early and late STR had a similar prognostic value (hazard ratios [95% confidence interval] for cardiac death 0.40 [0.08-2.03] and 0.25 [0.03-2.08]).

Conclusions. We found no (major) change in prognostic value of STR during the 0 to 90 minutes time window after PCI. (Neth Heart J 2010;18:416-22.)

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2
Figure 3

References

  1. van 't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet. 1997;350:615-9.

    Google Scholar 

  2. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 1999;99:1972-7.

    Google Scholar 

  3. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol. 1999;34:1932-8.

    Google Scholar 

  4. Santoro GM, Antoniucci D, Valenti R, Bolognese L, Buonamici P, Trapani M, et al. Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction. Am J Cardiol. 1997;80:685-9.

    Google Scholar 

  5. Brodie BR, Stuckey TD, Hansen C, VerSteeg DS, Muncy DB, Moore S, et al. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;95:343-8.

    Google Scholar 

  6. Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation. 2008;118:1335-46.

    Google Scholar 

  7. McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:1215-23.

    Google Scholar 

  8. Schroder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation. 2004;110(21):e506-10.

    Google Scholar 

  9. Gibson CM, Karha J, Giugliano RP, Roe MT, Murphy SA, Harrington RA, et al. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. Am Heart J. 2004;147:847-52.

    Google Scholar 

  10. Johanson P, Jernberg T, Gunnarsson G, Lindahl B, Wallentin L, Dellborg M. Prognostic value of ST-segment resolution-when and what to measure. Eur Heart J. 2003;24:337-45.

    Google Scholar 

  11. Schroder R, Dissmann R, Bruggemann T, Wegscheider K, Linderer T, Tebbe U, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 1994;24:384-91.

    Google Scholar 

  12. Terkelsen CJ, Norgaard BL, Lassen JF, Poulsen SH, Gerdes JC, Sloth E, et al. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study). Eur Heart J. 2006;27:267-75.

    Google Scholar 

  13. Watanabe J, Nakamura S, Sugiura T, Takehana K, Hamada S, Miyoshi H, et al. Early identification of impaired myocardial reperfusion with serial assessment of ST segments after percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol. 2001;88:956-9.

    Google Scholar 

  14. Krucoff MW, Green CE, Satler LF, Miller FC, Pallas RS, Kent KM, et al. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. Am J Cardiol. 1986;57:916-22.

    Google Scholar 

  15. Krucoff MW, Johanson P, Baeza R, Crater SW, Dellborg M. Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. Circulation. 2004;110:e533-9.

    Google Scholar 

  16. Schroder K, Wegscheider K, Zeymer U, Tebbe U, Schroder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet. 2001;358:1479-86.

    Google Scholar 

  17. Cura FA, Escudero AG, Berrocal D, Mendiz O, Trivi MS, Fernandez J, et al. Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). Am J Cardiol. 2007;99:357-63.

    Google Scholar 

  18. Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv. 2008;71:283-9.

    Google Scholar 

  19. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063-72.

    Google Scholar 

  20. De Carlo M, Wood DA, Webb JG, Gerckens U, Cortese B, Grube E, et al. Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry. Catheter Cardiovasc Interv. 2008;72:196-203.

    Google Scholar 

  21. Fischell TA. Pharmaceutical interventions for the management of no-reflow. J Invasive Cardiol. 2008;20:374-9.

    Google Scholar 

  22. Lee KW, Norell MS. Management of 'no-reflow' complicating reperfusion therapy. Acute Card Care. 2008;10:5-14.

    Google Scholar 

  23. Bainey KR, Senaratne MP. Is the outcomes of early ST-segment resolution after thrombolytic therapy in acute myocardial infarction always favorable? J Electrocardiol. 2005;38:354-60.

    Google Scholar 

  24. De Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Charlesworth A, et al. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. Am Heart J. 2000;140:373-8.

    Google Scholar 

  25. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009;374:1149-59.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands

Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands

Department of Epidemiology and Statistics, Erasmus University, Rotterdam, the Netherlands

Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, and Institute of Biomedical Technology, University of Twente, Enschede, the Netherlands

Department of Cardiology, Thoraxcenter, Erasmus MC, Room Ba 302, PO Box 2040, 3000 CA Rotterdam, the Netherlands

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van der Zwaan, H.B., Stoel, M.G., Roos-Hesselink, J.W. et al. Early versus late ST-segment resolution and clinical outcomes after percutaneous coronary intervention for acute myocardial infarction . NHJL 18, 416–422 (2010). https://doi.org/10.1007/BF03091808

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03091808

  • ST-Segment Resolution
  • Percutaneous Coronary Intervention
  • Acute Myocardial Infarction